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Introduction
Particulate systems are a class of drug delivery systems of great clinical and research interest for both local and systemic delivery, which are designed to improve drug bioavailability, stabilization, pharmacokinetics and selectivity, while avoiding toxicity issues raised by added excipients, continuous administration or tissue accumulation [1, 2] . Those systems are particularly appealing for pharmaceutical industry due to their versatility, enabling topical, pulmonary, nasal or parenteral administration [2, 3] in creams [4] , hydrogels [5] , dry powders and aerosols [6, 7] or injectable formulations [8] .
Drug loaded polymeric particles fabrication often rely on drying of a droplet containing the formulated mixtures from dissolved, dispersed or emulsified substances [9, 10] .
Most relevant techniques include spray-drying [7, 11] , spray freeze drying [12] , and electrospray [13] , among others. Spray-drying is a well-established technology in the pharmaceutical and food industry, for microencapsulation [14, 15] . This a continuous, single step, cost-effective and scalable technique that allows for the tuning of the final particles properties [9, 16] and for the processing of heat sensitive molecules (proteins, peptides or drugs) which, in turn, enhance the bioactivity of the final formulations [17, 18] . This is due to the fast solvent evaporation of droplets with high surface area-to-volume ratio [18] . Furthermore, the encapsulation of hydrophobic molecules is also possible by the atomization of emulsified feed solution, introducing then an extra processing step [19, 20] .
Natural polymers are often a smart choice when developing medical devices mainly due to their biocompatibility and biodegradability. Gelatin is a natural biopolymer, with a wide set of applications in the food, pharmaceutical and cosmetic industries,
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Despite its animal source, toxicity and antigenicity issues are minimal due to acid/alkali hydrolysis of collagen during processing [21, 22] . Other attractive features of gelatin for drug delivery systems include the available functional groups for the coupling of ligands, targeting or the stabilization by crosslinking, increasing circulation times [21] .
In this work, an alternative source of gelatin -fish gelatin -was chosen, which, considering the targeted application, would reduce the concerns about prion transmission related with animal sources of gelatin [23] .
Ciprofloxacin (CPx) is a broad-spectrum fluoroquinolone antibacterial agent indicated for the treatment of acute cystitis, chronic prostatitis, urinary and lower respiratory tract infections, acute sinusitis, skin infections, bone and joint infections, among others [24] . It is also administered to treat opportunistic Pseudomonas aeruginosa in cystic fibrosis patients [24] . CPx acts by inhibition of bacterial DNA gyrase and topoisomerase IV that disrupts bacterial DNA replication [25] . Side effects associated with CPx use, including gastrointestinal, cardiovascular and allergic reactions and nervous system complaints [26] , along with its poor water solubility and bioavailability [24, 27] motivates the development of effective encapsulations systems.
This work reports the development and optimization of gelatin microparticles for CPx encapsulation using an orthogonal design by a single-step procedure using spraydrying. The developed microparticles were characterized by SEM, FTIR and thermal analysis and the in vitro release profile was fitted to the mathematical release models.
The crosslinking effect (glutaraldehyde) on the microparticle diameter was also evaluated. CPx bioactivity was assessed by determining the minimal inhibitory and
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aureus (Gram-positive) comparing the CPx-loaded microparticles with the free drug.
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Material and methods
Materials
Gelatin (gel) from cold water fish skin, glutaraldehyde solution (GA; 50 wt.%) and ciprofloxacin (CPx; ≥ 98.0%) were supplied by Sigma-Aldrich. All reagents and chemicals used were of analytical grade.
Polymer particle processing
Gel solutions were prepared in double distilled water (ddH 2 O) at different concentrations (0.5, 1 and 2 % w/v) under magnetic stirring at 50 ºC and cooled to room temperature (25ºC) before use.
For gel-CPx formulations, a stock solution of CPx in 0.1N HCl was prepared separately and added to a gel solution (0.5 % w/v) for a final CPx concentration of 1, 2 and 5 wt%.
Spray-drying was performed using a home-made system (figure 1). The experimental parameters range for gelatin concentration, feed rate and inlet temperature are detailed in Table 1 .
Experimental design
The influence of the processing parameters on gel microparticles produced by spraydrying was evaluated by an orthogonal design 
where represents the orthogonal table of experiments, is the number of levels of each factor and is the maximum number of factors. To produce gel microparticles the
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The selection of optimal conditions was based on the orthogonal parameters K and R, which were calculated from the particle diameters as:
where and represents the mean and range values, respectively, for a factor at the level [28, 29] . The impact of the three factors (gel concentration, feed rate and inlet temperature) on the average particle diameter was evaluated by investigating the influence of different levels of each factor [28] . The determination of the factors order was achieved by calculating the range ( ) for each factor upon evaluation indexes ( ).
Rheology
The rheological behavior of gel solutions with different protein concentrations (0. A C C E P T E D M A N U S C R I P T 8
Polymer particles crosslinking
Dry particles were crosslinked using 20 mL of a glutaraldehyde solution (50 % in H 2 O, Sigma-Aldrich) in the vapor phase, in a vacuum chamber (VACUO-TEMP, JP Selecta, Spain), at room temperature, and under low pressure for 72 h.
Particles characterization
Particles were coated with a thin gold layer using a sputter coater (Smart Coater, JEOL)
and their morphology was analyzed using a scanning electron microscope (JCM-6000PLUS Neoscope, JEOL), with an accelerating voltage of 10 kV. Particles average diameter and its distribution was calculated over 300 particles in SEM images (1,000 x magnification) using the Image J software [30] . Particles dispersity was quantitatively evaluated by the coefficient of variation ( ), defined as:
where represents the standard deviation of the mean particle size ( ) [31] .
Infrared (FTIR) measurements were performed in a Shimadzu IRAffinity-1S apparatus in ATR mode from 4000 to 600 cm -1 , at room temperature. FTIR spectra were collected after 32 scans with a resolution of 2 cm -1 . Differential scanning calorimetry (DSC) measurements were performed with a TA Q100 apparatus (TAinstruments), between 30 and 200 ºC at a heating rate of 10 ºC.min -1 , under a nitrogen purge.
Thermogravimetrical analysis (TGA) was conducted in a Q500 apparatus (TAinstruments) using a heating rate scan of 20 ºC min -1 , under a nitrogen atmosphere.
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Determination of CPx loading
The CPx loading was determined by dissolving the dry gel-CPx microparticles in 0.1 M HCl, in ultrasonic bath for 6 h followed by mechanical stirring at 37 ºC. After 72 h, the suspensions were centrifuged (10,000 rpm, 10 min) to remove polymeric debris and the CPx was measured in the supernatants using a spectrophotometer (Shimadzu UV1800), using crosslinked drug-free gel particles as blank controls. The drug loading was calculated per equation 5, using a calibration curve of CPx in 0.1 M HCl (equation
, where is the drug concentration ( / ) and 2 is the coefficient of determination.
In vitro CPx release
Gel-CPx suspensions (10 mg mL using a UV-VIS spectrophotometer (Shimadzu UV1800) and the CPx amount was calculated using a calibration curve in PBS (7), where is the drug concentration
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( / ) and 2 is the coefficient of determination. Results were expressed as % cumulative release relative to the initial weight of CPx loaded in the particles. Analysis was performed in triplicates and results were averaged.
270
= 0.09847 + 0.001677 ( 2 = 0.998)
The experimental results were fitted to the first order (8), Higuchi (9) and KorsmeyerPeppas (10) models to further evaluate the release kinetics.
where and 0 are, respectively, the cumulative and initial amounts of drug, / ∞ is a fraction of drug released at time , is the rate constant, and is the exponent that characterizes the release mechanism [32, 33] .
Determination of the antibacterial activity of Gel-CPx particles
The susceptibility of Staphylococcus aureus (ATCC29213) and Escherichia coli (NCTC8196) to the gel-CPx (5 wt%) microparticles was evaluated by broth microdilution assay as previously described, with slight modifications [34] . Briefly, bacteria were streaked from glycerol-frozen stocks onto Luria-Bertani Agar (LB; ACCEPTED MANUSCRIPT
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Data analysis
Quantitative data are presented as mean ± standard deviation (SD). Significant differences were determined by one-way ANOVA analysis with Tukey`s HSD post hoc test using GraphPad Prism Software (v 6.01). Statistical differences were considered when < 0.05.
Results and discussion
Optimization of gelatin microparticles
The average particle diameter was the measured response of the orthogonal design to produce gel microparticles by spray-drying technique, in a single step, avoiding intermediate steps, such as emulsification. Results of average particle diameter, coefficient of variation and orthogonal indexes are presented in table 2, for the experimental runs from A to I (table 1) . The larger the parameter, the more influence of the factor on the process, reflecting either valuable or detrimental effects [28, 29, 35, 36] . For the processing of gel microparticles by spray-drying, gelatin concentration is the most important factor followed by the feed rate and the inlet temperature ( > > ). Figure 2 depicts the influence of tested factors and levels on the average particle diameter and coefficient of variance. Despite the narrow diameter range of the experimental runs (between 2.62 ± 0.78 and 3.65 ± 1.17 ), it can be pointed out a concentration-dependent increase in particle diameter (figure 2a)
that can be mainly addressed to the increased viscosity of the feed solution (figure 2b). lactose powders, where the increase in concentration lead to larger particles, although the effect was not linear [37] .
The influence of the tested factors and levels on the particles dispersity, quantitatively evaluated by the , were almost negligible, and similar values were found for all experimental runs, and all below 0.5 (table 2) . The water content in dry formulations is of outmost importance for the formulation preservation and for the improvement of shelf-life [38] . The overall variation in the moisture content for the orthogonal experiments (figure S1) was less than 2 % and, therefore, it is not influenced by the studied levels.
The selection of the optimal combination is determined by the smallest index and, for this work consisted of a feed concentration of 0.5% (w/v), using a feed rate of 308 ml h -1 at 115ºC. However, the optimal feed rate had to be adjusted for the subsequent experiments to the following level (177 ml h -1 ) due to the moisture introduced in the sample collector, that dissolved the formed particles and leading to a non-continuous processing.
The samples collected after spray-drying presented a mixture of wrinkled (mostly) and a few smooth spherical particles, as depicted in figure 3 , following a unimodal distribution (figure 4), in accordance with the lower values (table 2). Irregular particle morphology was already reported for gelatin microspheres [19] , and is usually ACCEPTED MANUSCRIPT
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14 associated with high Peclet numbers, which relates convection and diffusion phenomena and is influenced by the solvent evaporation rate [16] . Nevertheless, wrinkle-shaped albumin particles showed better performance in aerosolization studies due to its lower contact area that decreases the powder cohesiveness [39] .
Characterization of Gel-CPx particles
Ciprofloxacin (CPx)-loaded gelatin microparticles were produced by single-step spraydrying following the best experimental conditions determined in section 3.1. The gel crosslinking was performed in the vapor phase to improve particle stability, while diminishing possible cytotoxic effects associated with the crosslinking agent (GA) [19, 40] . Both uncross and crosslinked particles obtained by spray-drying presented a wrinkled surface morphology ( figure 5 a -d) like the ones observed in the orthogonal experiments ( figure 3) . Overall, the presence of CPx induced a narrower particle size distribution (figure 5 e -f), presenting a higher impact on the particle size rather than the crosslinking itself. Statistical differences were found between uncross and crosslinked samples only for 0 and 1 % wt CPx. It was reported that the use of GA as a crosslinking agent for gelatin, did not changed significantly the sample fiber diameter [41, 42] . Furthermore, the moisture content for the CPx-loaded formulations ( figure   S2 ) was comparable to the drug free ones.
Average diameters for CPx-loaded particles ranged from 2.73 ± 0.84 to 2.93 ± 0.86 for the uncrosslinked samples, and from 2.61 ± 0.70 to 2.79 ± 0.80 for the crosslinked ones. The crosslinking also lowered coefficient of variation, except for the highest CPx concentration.
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Considering the optimal particle size for the lung administration of small molecules, the obtained particle size shows potential to target the alveolar region. It was reported that particles in the narrow window of 1 -5 m, behave more like gas molecules and follow airflow all the way to the alveoli by a number of mechanisms, including diffusion, sedimentation, and electrostatic effects [43] . Particles in the range size of 1 -3 m are in peak of alveolar deposition [6, [44] [45] [46] .
CPx loading was carried out according to the procedure detailed in the experimental section, and the efficiency achieved was above 94 % (Table 3 ). Spray-drying of an aqueous solution of gelatin proved to be suitable to incorporate CPx, and thus, avoiding the incorporation of any other organic solvents in the mixture, being also environmentally friendly.
The infrared spectrum of pure CPx, gel and gel-CPx (5 %wt.) particles is depicted in figure 6 . The protein characteristic absorption bands were observed both in gel and gel-CPx particles at approximately 1650 cm -1 (amide I), 1540 cm -1 (amide II) and 1240 cm -1 (amide III), corresponding to the stretching vibrations of C=O bond, to the coupling of bending of N-H bond and stretching of C-N bonds, and to the stretching of C-N bonds plus the in-phase bending of N-H bonds, respectively [47, 48] . It was possible to observe the CPx absorption band at 1284 cm -1 , assigned to the C-N stretching [49] , in the microparticles FTIR spectra, confirming its presence in the drugloaded particles. Moreover, it can be observed that the particle processing does not suppress totally any absorption modes nor new vibrational modes seem to appear suggesting the absence of covalent bonds between gelatin and the drug.
Thermal analysis
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16 DSC curves of microparticles and free CPx are reported in figure 7a . CPx showed to be stable within the range of the processing temperatures. DSC data recorded for the pristine gelatin and gelatin loaded with CPx, showed similar trends, suggesting that the spray dry process does not influence the polymer thermal properties. A broad endothermic peak at lower temperatures, between 30 -120 ºC was attribute to the volatilization of absorbed and unbonded water present in the gelatin particles ( figure   7a ). The presence of water molecules in the particles is probably due to the storage and handling of the sample, at room conditions. Gelatin is a hygroscopic protein, and can trap up to 12 wt% of water from moisture [50, 51] . The characteristic helix-coil transformation of gelatin was detected at ~190 ºC [52] . Moreover, the enthalpy of the helix -coil decrease from 15.9 J g -1 for the pristine gelatin samples, down to 1.9 J g -1 for the sample loaded with 5 wt% of drug. These results suggest that the presence of CPx alters the formation of the characteristic helical structure, probably disrupting the hydrogen bonds between the polymer chains, by creating new hydrogen interactions between hydroxyl groups and amides present in both, drug and in the polymer chains [53] . Peña et al. reported that the incorporation of tannin in gelatin films, led to a decrease of the enthalpy of the helix-coil structure, from 15 J.g -1 , calculated for pristine gelatin films, down to 3 J g -1 , for a sample with 30 wt% tannin [53] . This behavior was attributed to the tannin ability to modify the hydrogen bonding between the protein chains, and creation of new hydrogen interactions between the tannin hydroxyl groups and gelatin polar groups.
Thermogravimetric analysis was performed to the prepared unloaded and loaded gelatin particles. Two different weight loss steps can be distinguished in figure 7b . The first one, between room temperature and 120 ºC, attributed to the loss of water
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17 absorbed during sample storage and handling [50, 53] . The second degradation step, that occurred between 250 -400 ºC, was attributed to the protein helix structure chain breakage, and peptide bonds rupture [53, 54] . The residual weight of the protein (≈35 wt%) agrees with the values reported in literature [54, 55] .
In vitro release studies
The cumulative in-vitro release of CPx carried out at physiological pH is depicted on figure 8a. All tested formulations presented a similar release profile where the complete release was achieved within 24 hours. The release profiles of the gel-CPx microparticles with different amounts of drug showed a burst release within the first 6
hours, followed by a slower release rate (figure 8a).
Gelatin particles can be seen as a polymeric network swollen with solvent, where the water fills the space between the strands of the polymer chains [56, 57] , and act as permeation channels. When the drug loaded particles are immersed in the release media, the polymer is capable to uptake the water based media, followed by relaxation of the macromolecular chains and volume expansion, and the CPx drug can diffuse to the external receptor medium from within the gelatin microparticle. The suggested mechanism for the CPx release is presented in figure 8b .
The obtained release profiles of the gelatin microparticles were in between of some gelatin systems reported in literature obtained via emulsion and desolvation techniques. The developed system had a more sustained release over time than a paclitaxel-loaded system with 90 % release in 2 h [58] , but a faster release compared with methotrexate-gelatin nanoparticles with a release profile over 150 h, depending
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18 on drug-gelatin ratio, and amount of poly(methyl methacrylate) present in the oil phase, during the preparation of the emulsion [56] .
The release profile was further investigated, and the experimental data was modelled to the first order, Higuchi and Korsmeyer-Peppas (KP) models, and the kinetic parameters are presented in table 4. The best fittings were obtained for first-order and KP models with coefficients of determination higher than 0.98.
Despite having similar profiles, the calculated release rate tends to increase with the increasing of drug loading in the system, an effect already reported [56] . According to KP model, a statistically significant increase in release rate was obtained between 1 wt.% and 2 wt.% formulations, which could be due to the high distance that the drug must travel from the core of the polymeric particle to the release medium, and consequently decreasing the release rate. However, no significance was obtained between those formulations and the 5 wt.% ones, being more similar to the 2 wt.%, which indicates that for contents above 2 wt.% the release rate is not influenced by spatial effects.
Berkland et al. [59] reported the effect of particle size (10 to 100 m) on drug release kinetics but such effect cannot be attributed to this gel-CPx system since the mean diameter differences are almost negligible ( figure 5 -f) . Thus, differences in values can be mainly addressed to geometrical factors, since particles having smaller drug loadings provide a larger path to the drug molecules to reach the release media ( figure   8b ).
Drug release from a polymeric system can be due to relaxation of the polymer chains over time, resulting in additive movement out of the polymer matrix; due to diffusion, where the drug moves out of the polymer matrix due to a concentration gradient ACCEPTED MANUSCRIPT
19 within the polymer, or degradation controlled, where part of the polymer dissolves in the release medium which causes the release of the drug present in that part of the polymer network [60, 61] . For the spray dried gelatin microparticles, drug release due to erosion of the polymer matrix is unlikely, as crosslinked gelatin does not dissolve under existent experimental conditions and its biodegradation starts at a time longer than that taken into consideration [50] . Thus, the mechanism of CPx release could be either diffusion or relaxation controlled, and can be elucidated by the value of the diffusion exponent (n) predicted by the KP model (equation 10). The value of n, summarized in table 4, suggests that a n value between 0.69 up to 0.75, and therefore, the release of CPx may be considered as an anomalous transport and indicate a superimposition of the two mechanisms -drug diffusion and polymer chain relaxation (0.43 < n < 0.85, for spherical systems) [32] .
MIC and MBC determination for CPx-loaded particles
The bioactivity of released ciprofloxacin was investigated by determining the minimal aureus [7, [62] [63] [64] and E. coli. [62] [63] [64] [65] . These results confirm the biological function of
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Conclusions
This work reports a facile and fast method of producing gelatin microparticles loaded with ciprofloxacin, a poorly water soluble antibacterial agent, with great potential for Spray-drying of protein-drug particle systems could be an advantageous alternative to emulsions, providing higher production rates, and given their features might have potential to lung administration of drugs. 
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Highlights
 A single step method to produce gelatin-ciprofloxacin microparticles is presented.  Spray-drying led to microparticles with suitable diameters for lung administration.  80 % of the encapsulated drug is released over 6 h, with MIC like the free drug.  This scalable method shows potential for dry systems in pharmaceutical industry.
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